Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK, PD, and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04733040
What this trial is testing

Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE)

Who this might be right for
GlomerulonephritisMembranous NephropathyantiPLA2R Positive
HI-Bio, A Biogen Company 24
Early research (Phase 1)Ended earlyNCT04855591
What this trial is testing

A Trial of SHR-1703 in Healthy Subjects

Who this might be right for
Asthma
Atridia Pty Ltd. 1
Early research (Phase 1)Study completedNCT04480697
What this trial is testing

Study of Safety, Tolerability and PK, PD of HPG1860 in Healthy Subjects

Who this might be right for
Healthy
Hepagene (Shanghai) Co., Ltd. 56
Early research (Phase 1)Study completedNCT00848510
What this trial is testing

EMD 525797 in Colorectal and Ovarian Cancer Patients With Liver Metastases

Who this might be right for
Colorectal and Ovarian Cancer Patients With Liver Metastases
Merck KGaA, Darmstadt, Germany 41
Early research (Phase 1)Not Yet RecruitingNCT07408908
What this trial is testing

Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of ACT100 in Healthy Participants..

Who this might be right for
Systemic Lupus ErythematosusCutaneous Lupus Erythematosus
Xiamen Amoytop Biotech Co., Ltd. 48
Early research (Phase 1)Study completedNCT03291782
What this trial is testing

D-0120 Safety and PK/PD, Food Effect Study in Healthy Volunteers

Who this might be right for
Gout
InventisBio Co., Ltd 39
Very early researchLooking for participantsNCT07274813
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced/Metastatic Solid TumorsNSCLC
Shanghai Henlius Biotech 254
Testing effectiveness (Phase 2)Study completedNCT02452242
What this trial is testing

Safety, PK and PD Study of ABX464 in Untreated HIV Patients

Who this might be right for
Human Immunodeficiency Virus Infections
Abivax S.A. 70
Early research (Phase 1)Ended earlyNCT06673069
What this trial is testing

Hero: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) and Pharmacodynamics (PD) of ION269 in Participants With Down Syndrome (DS) at Risk for Alzheimer's Disease (AD)

Who this might be right for
Alzheimer DiseaseDown Syndrome
Ionis Pharmaceuticals, Inc. 1
Early research (Phase 1)Study completedNCT03488186
What this trial is testing

PK-PD Comparative Study of Lansoprazole Capsules and Lansoprazole Enteric-coated Capsules in Healthy Chinese Volunteers

Who this might be right for
Effect of DrugsSafety Issues
First Affiliated Hospital of Zhejiang University 24
Testing effectiveness (Phase 2)Study completedNCT03923868
What this trial is testing

D-0120 Safety and PK/PD Study in China

Who this might be right for
Hyperuricemia or Gout
InventisBio Co., Ltd 52
Testing effectiveness (Phase 2)Study completedNCT00171730
What this trial is testing

An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly

Who this might be right for
Acromegaly
Novartis Pharmaceuticals 30
Early research (Phase 1)Study completedNCT01473108
What this trial is testing

Study to Investigate the Natriuretic Effects, Safety, Tolerability and Pharmacokinetics of BAY94-8862

Who this might be right for
Clinical Pharmacology
Bayer 67
Very early researchStudy completedNCT00602914
What this trial is testing

A Pilot Study to Assess the Safety, PK and PD of Insulin Injected Via MicronJet or Conventional Needle

Who this might be right for
Intradermal Injections
NanoPass Technologies Ltd 23
Early research (Phase 1)Study completedNCT02356224
What this trial is testing

The PK/PD Study of Single Dose of SHR3824 in Healthy Volunteers

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 84
Testing effectiveness (Phase 2)Study completedNCT02711956
What this trial is testing

ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Zenith Epigenetics 75
Early research (Phase 1)Ended earlyNCT04209179
What this trial is testing

A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidism

Who this might be right for
Hypoparathyroidism
Chugai Pharmaceutical 5
Early research (Phase 1)Study completedNCT06206811
What this trial is testing

Phase 1 Study to Investigate OD-07656 in Healthy Adult Participants

Who this might be right for
Inflammatory Bowel DiseasesBlau SyndromeCrohn Disease+2 more
Odyssey Therapeutics 101
Early research (Phase 1)Study completedNCT01971164
What this trial is testing

Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease

Who this might be right for
Anemia of Chronic Kidney Disease
Akros Pharma Inc. 29
Early research (Phase 1)Active Not RecruitingNCT07234864
What this trial is testing

Study to Assess Safety, Tolerability, PK, and PD of Multiple Doses of ZE63-0302 Administrated Orally in T2DM Patients.

Who this might be right for
Type 2 Diabetes
Eilean Therapeutics 60
Next Page